Synpromics Limited, a leading synthetic biology company, is pleased to announce that it has formed a collaboration with uniQure N.V., a world leader and pioneer in human gene therapy, to develop synthetic promoters with specific application in the delivery of gene medicines to liver.
Synpromics Limited, a privately held, Scottish-based synthetic biology company today announced that it has successfully generated several highly effective synthetic promoters for use in plants.
Collaborating with a leading multinational company is an exceptional achievement for this young biotechnology company, based at Edinburgh BioQuarter.
Synpromics, the synthetic promoter company, announces an important collaboration with Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), to develop Synpromics’ proprietary technology for application in plant science.
The BioIndustry Association (BIA) and UK Trade and Investment (UKTI) today announce the nine leading UK companies that will showcase UK expertise in synthetic biology (synbio) at SynBioBeta SF 2013, a key global synbio start-up conference taking place in California in November.